Literature DB >> 20303996

Pharmacological magnetic resonance imaging of muscarinic acetylcholine receptor activation in rat brain.

Erik I Hoff1, Robert J van Oostenbrugge, Wim M Otte, Kajo van der Marel, Harry W M Steinbusch, Rick M Dijkhuizen.   

Abstract

The central cholinergic system is involved in several cognitive functions such as attention, consciousness, learning and memory. Functional imaging of this neurotransmitter system may provide novel opportunities in the diagnosis and evaluation of cognitive disorders. The aim of this study was to investigate the spatial and temporal activation patterns of muscarinic acetylcholine receptor (mAChR) stimulation in rat brain with pharmacological magnetic resonance imaging (phMRI). We performed blood oxygenation level-dependent (BOLD) MRI and contrast-enhanced cerebral blood volume (CBV)-weighted MRI combined with injection of pilocarpine, a non-selective mAChR agonist. BOLD and CBV responses were assessed after pretreatment with methyl-scopolamine in order to block peripheral muscarinic effects. Region-of-interest analysis in individual animals and group-level independent component analysis failed to show significant BOLD signal changes following pilocarpine injection. However, with contrast-enhanced CBV-weighted MRI, positive CBV responses were detected in the cerebral cortex, thalamus, and hippocampus whereas a negative CBV response was observed in the striatum. Thus, pilocarpine-induced significant activation responses in brain regions that are known to have a high density of muscarinic receptors. Our study demonstrates that phMRI of mAChR stimulation in rats allows functional assessment of the cholinergic system in vivo. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303996     DOI: 10.1016/j.neuropharm.2010.03.007

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

Review 1.  Pharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain.

Authors:  Bruce G Jenkins
Journal:  Neuroimage       Date:  2012-04-01       Impact factor: 6.556

2.  Vascular action as the primary mechanism of cognitive effects of cholinergic, CNS-acting drugs, a rat phMRI BOLD study.

Authors:  Pál Kocsis; István Gyertyán; János Éles; Judit Laszy; Nikolett Hegedűs; Dávid Gajári; Levente Deli; Zsófia Pozsgay; Szabolcs Dávid; Károly Tihanyi
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-19       Impact factor: 6.200

3.  4-dimensional functional profiling in the convulsant-treated larval zebrafish brain.

Authors:  Matthew J Winter; Dylan Windell; Jeremy Metz; Peter Matthews; Joe Pinion; Jonathan T Brown; Malcolm J Hetheridge; Jonathan S Ball; Stewart F Owen; Will S Redfern; Julian Moger; Andrew D Randall; Charles R Tyler
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

4.  The cholinergic system modulates negative BOLD responses in the prefrontal cortex once electrical perforant pathway stimulation triggers neuronal afterdischarges in the hippocampus.

Authors:  Alberto Arboit; Karla Krautwald; Frank Angenstein
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-30       Impact factor: 6.200

Review 5.  Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive Decline.

Authors:  Marcelo Febo; Thomas C Foster
Journal:  Front Aging Neurosci       Date:  2016-06-29       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.